A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
for Alzheimer Disease
52 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 55+
Code: NCT07602582·Phase 3·Recruiting·Listed May 2026
Clinical research site in Phoenix, Arizona · 2901 N CENTRAL AVE STE 106, PHOENIX, AZ 85012-2700 · (602) 747-4000 · Website
As of July 2026, 7 paid clinical trials are recruiting at Banner Alzheimer?s Institute in Phoenix, Arizona. Active studies at this site cover conditions such as Alzheimer Disease, Dementia and Alzheimer Disease Due to P. Gingivalis. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Paid clinical trials in Phoenix, AZ · Arizona clinical trials